Chronic high-frequency stimulation of the subthalamic nucleus and L-DOPA treatment in experimental parkinsonism: Effects on motor behaviour and striatal glutamate transmission

European Journal of Neuroscience

Volumn 24, Issue 6, 2006, Pages 1802-1814

  Gubellini, Paolo ^a   Eusebio, Alexandre ^a,b   Oueslati, Abid ^a   Melon, Christophe ^a   Kerkerian Le Goff, Lydia ^a   Salin, Pascal ^a  

^a AIX MARSEILLE UNIVERSITÉ   (France)

^b TIMONE HOSPITAL   (France)

Author keywords

Akinesia; Electrophysiology; Glutamate; L DOPA induced dyskinesia; Rat; Striatum

Indexed keywords

GLUTAMIC ACID; LEVODOPA; OXIDOPAMINE;

AKINESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE EXACERBATION; DYSKINESIA; HIGH FREQUENCY STIMULATION; HYPERACTIVITY; LOCOMOTION; MALE; NEUROPATHOLOGY; NONHUMAN; PARKINSONISM; PATCH CLAMP; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SUBTHALAMIC NUCLEUS; SYNAPTIC TRANSMISSION;

ANIMALS; ANTIPARKINSON AGENTS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; DRUG INTERACTIONS; DYSKINESIAS; ELECTRIC STIMULATION; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; FUNCTIONAL LATERALITY; LEVODOPA; MALE; MEMBRANE POTENTIALS; OXIDOPAMINE; PARKINSONIAN DISORDERS; RATS; RATS, WISTAR; SUBTHALAMIC NUCLEUS; TIME FACTORS;

EID: 33748901821     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2006.05047.x     Document Type: Article

References (91)

1. Albin, R.L., Young, A.B. & Penney, J.B. (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci., 12, 366-375.
2. Arnt, J. & Hyttel, J. (1985) Differential involvement of dopamine D-1 and D-2 receptors in circling behaviour induced by apomorphine, SKF-38393, pergolide and LY 171555 in 6-hydroxydopamine-lesioned rats. Psychopharmacology (Berl.), 85, 346-352.
3. Baas, H. (2000) Dyskinesia in Parkinson's disease. Pathophysiology and clinical risk factors. J. Neurol., 247, 12-16.
4. Bacci, J.J., Absi el, H., Manrique, C., Baunez, C., Salin, P. & Kerkerian-Le Goff, L. (2004) Differential effects of prolonged high frequency stimulation and of excitotoxic lesion of the subthalamic nucleus on dopamine denervation-induced cellular defects in the rat striatum and globus pallidus. Eur. J. Neurosci., 20, 3331-3341.
5. Benabid, A.L., Benazzouz, A., Limousin, P., Koudsie, A., Krack, P., Piallat, B. & Pollak, P. (2000) Dyskinesias and the subthalamic nucleus. Ann. Neurol., 47, S189-S192.
6. Benabid, A.L., Pollak, P., Gross, C., Hoffmann, D., Benazzouz, A., Gao, D.M., Laurent, A., Gentil, M. & Perret, J. (1994) Acute and long-term effects of subthalamic nucleus stimulation in Parkinson's disease. Stereotact. Funct. Neurosurg., 62, 76-84.
7. Benazzouz, A., Boraud, T., Feger, J., Burbaud, P., Bioulac, B. & Gross, C. (1996) Alleviation of experimental hemiparkinsonism by high-frequency stimulation of the subthalamic nucleus in primates: a comparison with L-Dopa treatment. Mov. Disord., 11, 627-632.
8. Benazzouz, A., Gao, D., Ni, Z. & Benabid, A.L. (2000a) High frequency stimulation of the STN influences the activity of dopamine neurons in the rat. Neuroreport, 11, 1593-1596.
9. Benazzouz, A., Gao, D.M., Ni, Z.G., Piallat, B., Bouali-Benazzouz, R. & Benabid, A.L. (2000b) Effect of high-frequency stimulation of the subthalamic nucleus on the neuronal activities of the substantia nigra pars reticulata and ventrolateral nucleus of the thalamus in the rat. Neuroscience, 99, 289-295.
10. Benazzouz, A., Tai, C.H., Meissner, W., Bioulac, B., Bezard, E. & Gross, C. (2004) High-frequency stimulation of both zona incerta and subthalamic nucleus induces a similar normalization of basal ganglia metabolic activity in experimental parkinsonism. FASEB J., 18, 528-530.
11. Beurrier, C., Bioulac, B., Audin, J. & Hammond, C. (2001) High-frequency stimulation produces a transient blockade of voltage-gated currents in subthalamic neurons. J. Neurophysiol., 85, 1351-1356.
12. Blandini, F., Nappi, G., Tassorelli, C. & Martignoni, E. (2000) Functional changes of the basal ganglia circuitry in Parkinson's disease. Prog. Neurobiol., 62, 63-88.
13. Blandini, F., Porter, R.H. & Greenamyre, J.T. (1996) Glutamate and Parkinson's disease. Mol. Neurobiol., 12, 73-94.
14. Bruet, N., Windels, F., Bertrand, A., Feuerstein, C., Poupard, A. & Savasta, M. (2001) High frequency stimulation of the subthalamic nucleus increases the extracellular contents of striatal dopamine in normal and partially dopaminergic denervated rats. J. Neuropathol. Exp. Neurol., 60, 15-24.
15. Bruet, N., Windels, F., Carcenac, C., Feuerstein, C., Bertrand, A., Poupard, A. & Savasta, M. (2003) Neurochemical mechanisms induced by high frequency stimulation of the subthalamic nucleus: increase of extracellular striatal glutamate and GABA in normal and hemiparkinsonian rats. J. Neuropathol. Exp. Neurol., 62, 1228-1240.
16. Calabresi, P., Centonze, D. & Bernardi, G. (2000a) Electrophysiology of dopamine in normal and denervated striatal neurons. Trends Neurosci., 23, S57-S63.
17. Calabresi, P., Centonze, D., Gubellini, P., Marfia, G.A., Pisani, A., Sancesario, G. & Bernardi, G. (2000b) Synaptic transmission in the striatum: from plasticity to neurodegeneration. Prog. Neurobiol., 61, 231-265.
18. Calabresi, P., Maj, R., Pisani, A., Mercuri, N.B. & Bernardi, G. (1992b) Long-term synaptic depression in the striatum: physiological and pharmacological characterization. J. Neurosci., 12, 4224-4233.
19. Calabresi, P., Mercuri, N.B., Sancesario, G. & Bernardi, G. (1993) Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease. Brain, 116, 433-452.
20. Calabresi, P., Pisani, A., Mercuri, N.B. & Bernardi, G. (1992a) Long-term potentiation in the striatum is unmasked by removing the voltage-dependent magnesium block of NMDA receptor channels. Eur. J. Neurosci., 4, 929-935.
21. Carlsson, M. & Carlsson, A. (1990) Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease. Trends Neurosci., 13, 272-276.
22. Centonze, D., Gubellini, P., Rossi, S., Picconi, B., Pisani, A., Bernardi, G., Calabresi, P. & Baunez, C. (2005) Subthalamic nucleus lesion reverses motor abnormalities and striatal glutamatergic overactivity in experimental parkinsonism. Neuroscience, 133, 831-840.
23. Centonze, D., Picconi, B., Gubellini, P., Bernardi, G. & Calabresi, P. (2001) Dopaminergic control of synaptic plasticity in the dorsal striatum. Eur. J. Neurosci., 13, 1071-1077.
24. Chang, J.Y., Shi, L.H., Luo, F. & Woodward, D.J. (2003) High frequency stimulation of the subthalamic nucleus improves treadmill locomotion in unilateral 6-hydroxydopamine lesioned rats. Brain Res., 983, 174-184.
25. Charpier, S. & Deniau, J.M. (1997) In vivo activity-dependent plasticity at cortico-striatal connections: evidence for physiological long-term potentiation. Proc. Natl Acad. Sci. USA, 94, 7036-7040.
26. Chase, T.N. & Oh, J.D. (2000) Striatal mechanisms and pathogenesis of parkinsonian signs and motor complications. Ann. Neurol., 47, S122-S130.
27. Chen, M.T., Morales, M., Woodward, D.J., Hoffer, B.J. & Janak, P.H. (2001) In vivo extracellular recording of striatal neurons in the awake rat following unilateral 6-hydroxydopamine lesions. Exp. Neurol., 171, 72-83.
28. Choi, S. & Lovinger, D.M. (1997) Decreased probability of neurotransmitter release underlies striatal long-term depression and postnatal development of corticostriatal synapses. Proc. Natl Acad. Sci. USA, 94, 2665-2670.
29. Darbaky, Y., Forni, C., Amalric, M. & Baunez, C. (2003) High frequency stimulation of the subthalamic nucleus has beneficial antiparkinsonian effects on motor functions in rats, but less efficiency in a choice reaction time task. Eur. J. Neurosci., 18, 951-956.
30. Degos, B., Deniau, J.M., Thierry, A.M., Glowinski, J., Pezard, L. & Maurice, N. (2005) Neuroleptic-induced catalepsy: electrophysiological mechanisms of functional recovery induced by high-frequency stimulation of the subthalamic nucleus. J. Neurosci., 25, 7687-7696.
31. Dunah, A.W., Wang, Y., Yasuda, R.P., Kameyama, K., Huganir, R.L., Wolfe, B.B. & Standaert, D.G. (2000) Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease. Mol. Pharmacol., 57, 342-352.
32. Follett, K.A. (2004) Comparison of pallidal and subthalamic deep brain stimulation for the treatment of levodopa-induced dyskinesias. Neurosurg. Focus, 17, E3.
33. Garcia, L., Audin, J., D'Alessandro, G., Bioulac, B. & Hammond, C. (2003) Dual effect of high-frequency stimulation on subthalamic neuron activity. J. Neurosci., 23, 8743-8751.
34. Garcia, L., D'Alessandro, G., Bioulac, B. & Hammond, C. (2005) High-frequency stimulation in Parkinson's disease: more or less? Trends Neurosci., 28, 209-216.
35. Greenamyre, J.T. (2001) Glutamatergic influences on the basal ganglia. Clin. Neuropharmacol., 24, 65-70.
36. de Groot, J. (1959) The Rat Forebrain in Stereotaxic Coordinates. Verhandelingen der Koninklijke Nederlandse Akademic van Wetenschappen. AFD Natuurkunde NV, Noord-Hollandische Wetgevers Maatschappij, Amsterdam.
37. Gubellini, P., Picconi, B., Bari, M., Battista, N., Calabresi, P., Centonze, D., Bernardi, G., Finazzi-Agrò, A. & Maccarrone, M. (2002) Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission. J. Neurosci., 22, 6900-6907.
38. Gubellini, P., Pisani, A., Centonze, D., Bernardi, G. & Calabresi, P. (2004) Metabotropic glutamate receptors and striatal synaptic plasticity: implications for neurological diseases. Prog. Neurobiol., 74, 271-300.
39. Guridi, J., Luquin, M.R., Herrero, M.T. & Obeso, J.A. (1993) The subthalamic nucleus: a possible target for stereotaxic surgery in Parkinson's disease. Mov. Disord., 8, 421-429.
40. Jaffer, A., van der Spuy, G.D., Russell, V.A., Mintz, M. & Taljaard, J.J. (1995) Activation of the subthalamic nucleus and pedunculopontine tegmentum: does it affect dopamine levels in the substantia nigra, nucleus accumbens and striatum? Neurodegeneration, 4, 139-145.
41. Javitch, J.A., Strittmatter, S.M. & Snyder, S.H. (1985) Differential visualization of dopamine and norepinephrine uptake sites in rat brain using [3H]mazindol autoradiography. J. Neurosci., 5, 1513-1521.
42. Jiang, Z.G. & North, R.A. (1991) Membrane properties and synaptic responses of rat striatal neurones in vitro. J. Physiol., 443, 533-553.
43. Katayama, Y., Kasai, M., Oshima, H., Fukaya, C., Yamamoto, T., Ogawa, K. & Mizutani, T. (2001) Subthalamic nucleus stimulation for Parkinson disease: benefits observed in levodopa-intolerant patients. J. Neurosurg., 95, 213-221.
44. Kita, T., Kita, H. & Kitai, S.T. (1984) Passive electrical membrane properties of rat neostriatal neurons in an in vitro slice preparation. Brain Res., 300, 129-139.
45. Kita, H. & Kitai, S.T. (1987) Efferent projections of the subthalamic nucleus in the rat: Light and electron microscopic analysis with the PHA-L method. J. Comp. Neurol., 260, 435-452.
46. Klockgether, T., Loschmann, P.A. & Wullner, U. (1994) New medical and surgical treatments for Parkinson's disease. Curr. Opin. Neurol., 7, 346-352.
47. Krack, P., Fraix, V., Mendes, A., Benabid, A.L. & Pollak, P. (2002) Postoperative management of subthalamic nucleus stimulation for Parkinson's disease. Mov. Disord., 17, S188-S197.
48. Lang, A.E. & Lozano, A.M. (1998a) Parkinson's disease. First of two parts. N. Engl. J. Med., 339, 1130-1143.
49. Lang, A.E. & Lozano, A.M. (1998b) Parkinson's disease. Second of two parts. N. Engl. J. Med., 339, 1044-1153.
50. Lee, K.H., Chang, S.Y., Roberts, D.W. & Kim, U. (2004) Neurotransmitter release from high-frequency stimulation of the subthalamic nucleus. J. Neurosurg., 101, 511-517.
51. Lee, K.H., Roberts, D.W. & Kim, U. (2003) Effect of high-frequency stimulation of the subthalamic nucleus on subthalamic neurons: an intracellular study. Stereotact. Funct. Neurosurg., 80, 32-36.
52. Limousin, P., Pollak, P., Benazzouz, A., Hoffmann, D., Le Bas, J.F., Broussolle, E., Perret, J.E. & Benabid, A.L. (1995) Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet, 345, 91-95.
53. Lozano, A.M. & Mahant, N. (2004) Deep brain stimulation surgery for Parkinson's disease: mechanisms and consequences. Parkinsonism Relat. Disord., 10, S49-S57.
54. Lundblad, M., Andersson, M., Winkler, C., Kirik, D., Wierup, N. & Cenci, M.A. (2002) Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease. Eur. J. Neurosci., 15, 120-132.
55. Maccarrone, M., Gubellini, P., Bari, M., Picconi, B., Battista, N., Centonze, D., Bernardi, G., Finazzi-Agrò, A. & Calabresi, P. (2003) Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism. J. Neurochem., 85, 1018-1025.
56. Magarinos-Ascone, C., Pazo, J.H., Macadar, O. & Buno, W. (2002) High-frequency stimulation of the subthalamic nucleus silences subthalamic neurons: a possible cellular mechanism in Parkinson's disease. Neuroscience, 115, 1109-1117.
57. Maurice, N., Thierry, A.M., Glowinski, J. & Deniau, J.M. (2003) Spontaneous and evoked activity of substantia nigra pars reticulata neurons during high-frequency stimulation of the subthalamic nucleus. J. Neurosci., 23, 9929-9936.
58. McIntyre, C.C., Savasta, M., Kerkerian-Le Goff, L. & Vitek, J.L. (2004) Uncovering the mechanism(s) of action of deep brain stimulation: activation, inhibition, or both. Clin. Neurophysiol., 115, 1239-1248.
59. Meissner, W., Harnack, D., Reese, R., Paul, G., Reum, T., Ansorge, M., Kusserow, H., Winter, C., Morgenstern, R. & Kupsch, A. (2003) High-frequency stimulation of the subthalamic nucleus enhances striatal dopamine release and metabolism in rats. J. Neurochem., 85, 601-609.
60. Meissner, W., Leblois, A., Hansel, D., Bioulac, B., Gross, C.E., Benazzouz, A. & Boraud, T. (2005) Subthalamic high frequency stimulation resets subthalamic firing and reduces abnormal oscillations. Brain, 128, 2372-2382.
61. Molinuevo, J.L., Valldeoriola, F., Tolosa, E., Rumia, J., Valls-Sole, J., Roldan, H. & Ferrer, E. (2000) Levodopa withdrawal after bilateral subthalamic nucleus stimulation in advanced Parkinson disease. Arch. Neurol., 57, 983-988.
62. Nutt, J.G., Rufener, S.L., Carter, J.H., Anderson, V.C., Pahwa, R., Hammerstad, J.P. & Burchiel, K.J. (2001) Interactions between deep brain stimulation and levodopa in Parkinson's disease. Neurology, 57, 1835-1842.
63. Olanow, C.W., Brin, M.F. & Obeso, J.A. (2000) The role of deep brain stimulation as a surgical treatment for Parkinson's disease. Neurology, 55, S60-S66.
64. Olanow, C.W. & Obeso, J.A. (2000) Pulsatile stimulation of dopamine receptors and levodopa-induced motor complications in Parkinson's disease: implications for the early use of COMT inhibitors. Neurology, 55, S72-S81.
65. Orr, W.B., Stricker, E.M., Zigmond, M.J. & Berger, T.W. (1987) Effects of dopamine depletion on the spontaneous activity of type I striatal neurons: relation to local dopamine concentration and motor behavior. Synapse, 1, 461-469.
66. Parent, A. & Hazrati, L.N. (1995) Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res. Brain Res. Rev., 20, 128-154.
67. Paul, G., Reum, T., Meissner, W., Marburger, A., Sohr, R., Morgenstern, R. & Kupsch, A. (2000) High frequency stimulation of the subthalamic nucleus influences striatal dopaminergic metabolism in the naive rat. Neuroreport, 11, 441-444.
68. Paxinos, G. & Watson, C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
69. Picconi, B., Centonze, D., Hakansson, K., Bernardi, G., Greengard, P., Fisone, G., Cenci, M.A. & Calabresi, P. (2003) Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia. Nat. Neurosci., 6, 501-506.
70. Picconi, B., Centonze, D., Rossi, S., Bernardi, G. & Calabresi, P. (2004) Therapeutic doses of 1-dopa reverse hypersensitivity of corticostriatal D2-dopamine receptors and glutamatergic overactivity in experimental parkinsonism. Brain, 127, 1661-1669.
71. Picconi, B., Pisani, A., Centonze, D., Battaglia, G., Storto, M., Nicoletti, F., Bernardi, G. & Calabresi, P. (2002) Striatal metabotropic glutamate receptor function following experimental parkinsonism and chronic levodopa treatment. Brain, 125, 2635-2645.
72. Pisani, A., Centonze, D., Bernardi, G. & Calabresi, P. (2005) Striatal synaptic plasticity: implications for motor learning and Parkinson's disease. Mov. Disord., 20, 395-402.
73. Pisani, A., Gubellini, P., Bonsi, P., Conquet, F., Picconi, B., Centonze, D., Bernardi, G. & Calabresi, P. (2001) Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons. Neuroscience, 106, 579-587.
74. Poewe, W.H., Lees, A.J. & Stern, G.M. (1986) Treatment of motor fluctuations in Parkinson's disease with an oral sustained-release preparation of 1-dopa: clinical and pharmacokinetic observations. Clin. Neuropharmacol., 9, 430-439.
75. Rascol, O. (2000) Medical treatment of levodopa-induced dyskinesias. Ann. Neurol., 47, S179-S188.
76. Rascol, O., Payoux, P., Ory, F., Ferreira, J.J., Brefel-Courbon, C. & Montastruc, J.L. (2003) Limitations of current Parkinson's disease therapy. Ann. Neurol., 53, S3-S15.
77. Robelet, S., Melon, C., Guillet, B., Salin, P. & Kerkerian-Le Goff, L. (2004) Chronic L-DOPA treatment increases extracellular glutamate levels and GLT1 expression in the basal ganglia in a rat model of Parkinson's disease. Eur. J. Neurosci., 20, 1255-1266.
78. Rodriguez-Oroz, M.C., Gorospe, A., Guridi, J., Ramos, E., Linazasoro, G., Rodriguez-Palmero, M. & Obeso, J.A. (2000) Bilateral deep brain stimulation of the subthalamic nucleus in Parkinson's disease. Neurology, 55, S45-S51.
79. Rodriguez-Oroz, M.C., Obeso, J.A., Lang, A.E., Houeto, J.L., Pollak, P., Rehncrona, S. et al. (2005) Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain, 128, 2240-2249.
80. Rodriguez-Oroz, M.C., Zamarbide, I., Guridi, J., Palmero, M.R. & Obeso, J.A. (2004) Efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson's disease 4 years after surgery: double blind and open label evaluation. J. Neurol. Neurosurg. Psychiatry, 75, 1382-1385.
81. Salin, P., Manrique, C., Forni, C. & Kerkerian-Le Goff, L. (2002) High-frequency stimulation of the subthalamic nucleus selectively reverses dopamine denervation-induced cellular defects in the output structures of the basal ganglia in the rat. J. Neurosci., 22, 5137-5148.
82. Schwartig, R.K.W. & Huston, J.P. (1996) The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Prog. Neurobiol., 50, 275-231.
83. Starr, M.S. (1995) Glutamate/dopamine D1/D2 balance in the basal ganglia and its relevance to Parkinson's disease. Synapse, 19, 264-293.
84. Tai, C.H., Boraud, T., Bezard, E., Bioulac, B., Gross, C. & Benazzouz, A. (2003) Electrophysiological and metabolic evidence that high-frequency stimulation of the subthalamic nucleus bridles neuronal activity in the subthalamic nucleus and the substantia nigra reticulata. FASEB J., 17, 1820-1830.
85. Temel, Y., Visser-Vandewalle, V., Aendekerk, B., Rutten, B., Tan, S., Scholtissen, B., Schmitz, C., Blokland, A. & Steinbusch, H.W. (2005) Acute and separate modulation of motor and cognitive performance in parkinsonian rats by bilateral stimulation of the subthalamic nucleus. Exp. Neurol., 193, 43-52.
86. Tseng, K.Y., Kasanetz, F., Kargieman, L., Riquelme, L.A. & Murer, M.G. (2001) Cortical slow oscillatory activity is reflected in the membrane potential and spike trains of striatal neurons in rats with chronic nigrostriatal lesions. J. Neurosci., 21, 6430-6439.
87. Wichmann, T. & DeLong, M.R. (2003) Functional neuroanatomy of the basal ganglia in Parkinson's disease. Adv. Neurol., 91, 9-18.
88. Wilson, C.J. & Kawaguchi, Y. (1996) The origins of two-state spontaneous membrane potential fluctuations of neostriatal spiny neurons. J. Neurosci., 16, 2397-2410.
89. Windels, F., Bruet, N., Poupard, A., Urbain, N., Chouvet, G., Feuerstein, C. & Savasta, M. (2000) Effects of high frequency stimulation of subthalamic nucleus on extracellular glutamate and GABA in substantia nigra and globus pallidus in the normal rat. Eur. J. Neurosci., 12, 4141-4146.
90. Windels, F., Carcenac, C., Poupard, A. & Savasta, M. (2005) Pallidal origin of GABA release within the substantia nigra pars reticulata during high-frequency stimulation of the subthalamic nucleus. J. Neurosci., 25, 5079-5086.
91. Winkler, C., Kirik, D., Bjorklund, A. & Cenci, M.A. (2002) L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson's disease: relation to motor and cellular parameters of nigrostriatal function. Neurobiol. Dis., 10, 165-186.